Compare VBIX & KYNB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | VBIX | KYNB |
|---|---|---|
| Founded | N/A | 1993 |
| Country | Israel | United States |
| Employees | 21 | 34 |
| Industry | Computer Software: Prepackaged Software | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 30.1M | 27.6M |
| IPO Year | N/A | N/A |
| Metric | VBIX | KYNB |
|---|---|---|
| Price | $3.60 | $6.94 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 25.6K | 6.1K |
| Earning Date | 05-13-2026 | 05-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $0.15 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.96 | $6.32 |
| 52 Week High | $6.31 | $9.58 |
| Indicator | VBIX | KYNB |
|---|---|---|
| Relative Strength Index (RSI) | 88.05 | 48.34 |
| Support Level | $2.54 | $6.67 |
| Resistance Level | $3.70 | $7.42 |
| Average True Range (ATR) | 0.22 | 0.17 |
| MACD | 0.12 | -0.01 |
| Stochastic Oscillator | 98.39 | 39.58 |
ViewBix Inc operates in the field of digital advertising. The company operates in single segment, the search segment that develops various technological software solutions, which perform automation, optimization, and monetization of internet campaigns, to obtain and route internet user traffic to its customers.
Kyntra Bio Inc is a biopharmaceutical company focused on the development of novel therapies in oncology and rare disease. The company's research programs target cancer and rare disease indications, including anemia associated with lower-risk myelodysplastic syndrome (LR-MDS) and metastatic castration-resistant prostate cancer (mCRPC). Itd pipeline drug candidates include Roxadustat and FG-3246.